Abbott Laboratories
SIX:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
SIX:ABT
Watchlist
Price: 91.0424 CHF -4.17%
Market Cap: 239.4B CHF
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ABT stock under the Base Case scenario is 93.1856 CHF. Compared to the current market price of 91.0424 CHF, Abbott Laboratories is Undervalued by 2%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABT Relative Value
Base Case
93.1856 CHF
Undervaluation 2%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.4
P/S
P/S
Price to Sales
5.4
vs History
22
vs Industry
25
Median 3Y
4.7
Median 5Y
4.8
Industry
2.4
Forward
5.1
More Details
16.5
P/E
P/E
Price to Earnings
16.5
vs History
95
vs Industry
31
Median 3Y
29.9
Median 5Y
31.3
Industry
22.4
Forward
25.5
More Details
25.8
P/OCF
P/OCF
Price to OCF
25.8
vs History
22
vs Industry
14
Median 3Y
24.6
Median 5Y
23.4
Industry
14.4
More Details
44.8
P/FCFE
P/FCFE
Price to FCFE
44.8
vs History
31
vs Industry
9
Median 3Y
43.7
Median 5Y
34.9
Industry
21.2
More Details
4.7
P/B
P/B
Price to Book Value
4.7
vs History
73
vs Industry
17
Median 3Y
4.8
Median 5Y
5
Industry
2.3
More Details
5.5
EV/S
EV/S
Enterprise Value to Sales
5.5
vs History
28
vs Industry
23
Median 3Y
4.8
Median 5Y
5
Industry
2.6
Forward
5.2
More Details
9.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.8
vs History
26
vs Industry
22
Median 3Y
8.6
Median 5Y
8.9
Industry
5.3
More Details
21.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.8
vs History
23
vs Industry
15
Median 3Y
19.7
Median 5Y
19.7
Industry
12
Forward
19.7
More Details
30.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
30.7
vs History
28
vs Industry
13
Median 3Y
28.9
Median 5Y
28.8
Industry
16.6
Forward
22.5
More Details
26.4
EV/OCF
EV/OCF
Enterprise Value to OCF
26.4
vs History
28
vs Industry
14
Median 3Y
25.5
Median 5Y
24.2
Industry
14.6
More Details
35.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
35.6
vs History
34
vs Industry
13
Median 3Y
34.8
Median 5Y
32.5
Industry
18.3
More Details
3.4
EV/IC
EV/IC
Enterprise Value to IC
3.4
vs History
33
vs Industry
25
Median 3Y
3.2
Median 5Y
3.2
Industry
1.9
More Details

Multiples Across Competitors

ABT Competitors Multiples
Abbott Laboratories Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Abbott Laboratories
SIX:ABT
230.8B CHF 5.4 16.5 21.8 30.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
163.4B USD 17.9 62.7 48.6 58.4
US
Boston Scientific Corp
NYSE:BSX
154.5B USD 8.4 61.7 34.6 47.7
US
Stryker Corp
NYSE:SYK
148.6B USD 6.2 50.9 25.2 30.4
IE
Medtronic PLC
NYSE:MDT
120.8B USD 3.5 25.9 14.2 20.4
DE
Siemens Healthineers AG
XETRA:SHL
54B EUR 2.3 24.9 13.9 19.6
US
Becton Dickinson and Co
NYSE:BDX
54.6B USD 2.6 34 13.1 23.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.7B USD 12.8 52.5 37.7 41.9
US
Edwards Lifesciences Corp
NYSE:EW
45.7B USD 8 11 24.4 26.7
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
292.2B CNY 8.9 31.8 27.8 27.8
US
Resmed Inc
NYSE:RMD
40.2B USD 7.8 28.5 20.6 23.5

See Also

Summary
ABT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ABT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABT stock valuation using valuation multiples.
Wall Street Estimates
ABT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 281,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.